These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17874140)

  • 1. Selective late steroid withdrawal after renal transplantation.
    Laube GF; Falger J; Kemper MJ; Zingg-Schenk A; Neuhaus TJ
    Pediatr Nephrol; 2007 Nov; 22(11):1947-52. PubMed ID: 17874140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
    Oberholzer J; John E; Lumpaopong A; Testa G; Sankary HN; Briars L; Kraft KA; Knight PS; Verghese P; Benedetti E
    Pediatr Transplant; 2005 Aug; 9(4):456-63. PubMed ID: 16048597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years.
    Jungraithmayr T; Staskewitz A; Kirste G; Böswald M; Bulla M; Burghard R; Dippell J; Greiner C; Helmchen U; Klare B; Klaus G; Leichter HE; Mihatsch MJ; Michalk DV; Misselwitz J; Plank C; Querfeld U; Weber LT; Wiesel M; Tönshoff B; Zimmerhackl LB;
    Transplantation; 2003 Feb; 75(4):454-61. PubMed ID: 12605109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
    Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil.
    Höcker B; Weber LT; Feneberg R; Drube J; John U; Fehrenbach H; Pohl M; Zimmering M; Fründ S; Klaus G; Wühl E; Tönshoff B
    Transplantation; 2009 Mar; 87(6):934-41. PubMed ID: 19300199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rejection is a strong graft survival predictor in live donor pediatric renal transplantation using cyclosporine, mycophenolate mofetil, and steroids: 5-year outcomes in a single Mexican center.
    Martinez-Mier G; Enriquez-De Los Santos H; Méndez-López MT; Avila-Pardo SF; Budar-Fernandez LF; Gonzalez-Velazquez F
    Transplant Proc; 2013 May; 45(4):1442-4. PubMed ID: 23726592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
    Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
    J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we eliminate both calcineurin inhibitors and steroids?
    Lebranchu Y
    Transplant Proc; 2010 Nov; 42(9 Suppl):S25-8. PubMed ID: 21095446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney graft outcomes in living-related transplantation have improved with substitution of basiliximab and mycophenolate mofetil for antithymocyte globulin and azathioprine: a single center retrospective cohort study.
    Imamović G; Zerem E; Osmanović E
    Eur J Intern Med; 2010 Dec; 21(6):524-9. PubMed ID: 21111938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients.
    Diem HV; Sokal EM; Janssen M; Otte JB; Reding R
    Transplantation; 2003 May; 75(10):1664-70. PubMed ID: 12777853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of azathioprine versus mycophenolate mofetil in cyclosporine-based immunosuppression in kidney transplantation: 10 years of experience at a single center.
    Kwon O; Cho JH; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transplant Proc; 2013 May; 45(4):1487-90. PubMed ID: 23726603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation.
    Höcker B; Weber LT; Feneberg R; Drube J; John U; Fehrenbach H; Pohl M; Zimmering M; Fründ S; Klaus G; Wühl E; Tönshoff B
    Nephrol Dial Transplant; 2010 Feb; 25(2):617-24. PubMed ID: 19793929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.
    Wlodarczyk Z; Walaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradszky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Kalmar KN; Hickey D
    Transpl Int; 2005 Feb; 18(2):157-62. PubMed ID: 15691267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA; Gheith OA; Ismael AM; Baz ME; Shehab El-Dein AB; Ghoneim MA
    Exp Clin Transplant; 2008 Mar; 6(1):48-53. PubMed ID: 18405245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
    Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G
    Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients.
    Oh CK; Huh KH; Ha J; Kim YH; Kim YL; Kim YS
    Transplantation; 2015 Jan; 99(1):180-6. PubMed ID: 24983307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early steroid withdrawal in adult kidney transplantation at a single center.
    Iwamoto H; Hama K; Konno O; Yokoyama T; Kihara Y; Jojima Y; Nakamura Y; Takeuchi H; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):179-81. PubMed ID: 22310609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.